All In Biotech

Drug Trial Radar · NCT07775404

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus (EMBOLD-Asia)

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 351 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

351

Planned (sponsor's estimate)

Start

Aug 21, 2026

Primary completion

Apr 6, 2028

Study completion Apr 13, 2028

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Aug 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adult participants living with obesity or overweight with or without T2DM.

Conditions

  • Obesity
  • Overweight

Interventions

  • ElecoglipronDrug

    Elecoglipron film coated tablet once daily

  • PlaceboDrug

    Placebo matching elecoglipron film-coated tablet once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change from baseline to Week 52 in body weightTime frame: Week 52
  2. Participants achieving at least 5% body weight loss at Week 52Time frame: Week 52

Locations

49 sites in 5 countries. Site status is shown where the registry gives one.

  • Research Site

    Baotou, China · Not yet recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Not yet recruiting

  • Research Site

    Changde, China · Recruiting

  • Research Site

    Changsha, China · Recruiting

  • Research Site

    Changzhou, China · Recruiting

  • Research Site

    Chengdu, China · Recruiting

  • Research Site

    Hefei, China · Recruiting

  • Research Site

    Huangshi, China · Recruiting

  • Research Site

    Jincheng, China · Recruiting

  • Research Site

    Jinzhou Shi, China · Not yet recruiting

  • Research Site

    Langfang, China · Recruiting

  • Research Site

    Luoyang, China · Not yet recruiting

  • Research Site

    Meihekou, China · Recruiting

  • Research Site

    Nanjing, China · Recruiting

  • Research Site

    Nanyang, China · Recruiting

  • Research Site

    Nanyang, China · Recruiting

  • Research Site

    Shanghai, China · Recruiting

  • Research Site

    Shantou, China · Recruiting

  • Research Site

    Shenyang, China · Recruiting

  • Research Site

    Shenyang, China · Recruiting

  • Research Site

    Shijiazhuang, China · Recruiting

  • Research Site

    Wuhan, China · Withdrawn

  • Research Site

    Wuhu, China · Recruiting

  • Research Site

    Xianyang, China · Recruiting

  • Research Site

    Xuzhou, China · Recruiting

  • Research Site

    Yan’an, China · Recruiting

  • Research Site

    Yueyang, China · Recruiting

  • Research Site

    Zhumadian, China · Recruiting

  • Research Site

    Zibo, China · Recruiting

  • Research Site

    Hong Kong, Hong Kong · Recruiting

  • Research Site

    Shatin, Hong Kong, Hong Kong · Recruiting

  • Research Site

    Alor Star, Malaysia · Recruiting

  • Research Site

    Kuala Lumpur, Malaysia · Recruiting

  • Research Site

    Kuching, Malaysia · Recruiting

  • Research Site

    Putrajaya, Malaysia · Recruiting

  • Research Site

    Sarawak Miri, Malaysia · Recruiting

  • Research Site

    Seremban, Malaysia · Not yet recruiting

  • Research Site

    Seri Manjung, Malaysia · Recruiting

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.